You are here
February 3, 2014
An Unusual Partnership to Tackle Stubborn Diseases
In the New York Times, Dr. Collins lauds the Accelerating Medicines Partnership as a unique collaboration which will work towards expediting the identification of new drug targets for three major disease areas.
This page last reviewed on March 13, 2015